Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 14, 2011
Patent Application Number
12760354
Date Filed
April 14, 2010
Patent Primary Examiner
Patent abstract
The present invention is directed to novel polypeptides designated herein as EG-VEGF and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Also provided herein are methods of screening for modulators of EG-VEGF. Furthermore, methods and related methods of treatment are described herein which pertain to regulating cellular proliferation and chemotaxis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
